Cantitate/Preț
Produs

Predictive Approaches in Drug Discovery and Development

Editat de J Andrew Williams, Richard Lalonde, Jeffrey R Koup, David D Christ, Sean Ekins
en Limba Engleză Hardback – 10 apr 2012
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Citește tot Restrânge

Preț: 90064 lei

Preț vechi: 98972 lei
-9% Nou

Puncte Express: 1351

Preț estimativ în valută:
15937 18688$ 13996£

Carte tipărită la comandă

Livrare economică 03-17 februarie 26

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470170830
ISBN-10: 0470170832
Pagini: 416
Dimensiuni: 161 x 240 x 26 mm
Greutate: 0.78 kg
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Pharmaceutical scientists pursing drug research and development, including management, bench–level pharmacologists, and toxicologists; Clinical pharmacologists and clinicians, ADME/Tox and pharmaceutical scientists and students; Pharmaceutical companies interested in improving decision making and reducing costs; Regulatory agencies like the US FDA and EPA, British MHRA, and other European and Japanese equivalents.

Notă biografică

J. Andrew Williams, PHD, is Director of Translational Oncology at Pfizer Oncology. Richard Lalonde, PharmD, is Vice President and Global Head of Clinical Pharmacology at Pfizer. Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner of Lakeside PKPD, LLC. David D. Christ, PHD, is a consultant with SNC Partners LLC.

Descriere

Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.